Active Member Straws

×

Add a Straw

Note: Maximum file size should not exceed 2 MB and file type should be JPG, PNG, PDF or DOC.
Private — only you will be able to see this Straw
Added 2 months ago
#Bull Case

Speculative share with great results  ATL1102 drug, used in the treatment of DMD. 

Antisense is looking to advance ATL1102 into a potentially pivotal Phase IIb clinical trial with the goal of providing treatment options to all, not just some, of the boys with DMD.

Due to Antisense's recent trial results, the addressable markets it can target and the positive momentum in the space it operates, Antisense is a key stock to consider, particularly as there are no other listed companies working in this space.

mangement buying shares on the market. Good sign